These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18193927)

  • 41. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.
    Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S;
    Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacotherapy of epilepsy: the use of topiramate in initial and additional treatment].
    Rudakova IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6 Pt 2):58-64. PubMed ID: 22983246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topiramate: uses in people with an intellectual disability who have epilepsy.
    Kerr MP
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():74-9. PubMed ID: 10030437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group.
    Biton V; Montouris GD; Ritter F; Riviello JJ; Reife R; Lim P; Pledger G
    Neurology; 1999 Apr; 52(7):1330-7. PubMed ID: 10227614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topiramate for drug-resistant epilepsies.
    Yeung S; Ferrie CD; Murdoch-Eaton DG; Livingston JH
    Eur J Paediatr Neurol; 2000; 4(1):31-3. PubMed ID: 10701102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxcarbazepine: an update of its efficacy in the management of epilepsy.
    Wellington K; Goa KL
    CNS Drugs; 2001; 15(2):137-63. PubMed ID: 11460891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pilot study of Topiramate (Topamax) in the treatment of tonic-clonic seizures of alcohol withdrawal syndromes.
    Rustembegovic A; Sofic E; Kroyer G
    Med Arh; 2002; 56(4):211-2. PubMed ID: 12518536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G; Abou-Khalil B
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spotlight on oxcarbazepine in epilepsy.
    Bang LM; Goa KL
    CNS Drugs; 2004; 18(1):57-61. PubMed ID: 14731060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tolerability and safety of topiramate in Chinese patients with epilepsy : an open-label, long-term, prospective study.
    Lu Y; Wang X; Li Q; Li J; Yan Y
    Clin Drug Investig; 2007; 27(10):683-90. PubMed ID: 17803343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.
    Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE;
    Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topiramate: a review of preclinical, pharmacokinetic, and clinical data.
    Rosenfeld WE
    Clin Ther; 1997; 19(6):1294-308. PubMed ID: 9444441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topiramate in the catastrophic epilepsies of childhood.
    Glauser TA
    J Child Neurol; 2000; 15 Suppl 1():S14-21. PubMed ID: 11218052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and tolerability of topiramate in children younger than 2 years old.
    Valencia I; Fons C; Kothare SV; Khurana DS; Yum S; Hardison HH; Legido A
    J Child Neurol; 2005 Aug; 20(8):667-9. PubMed ID: 16225812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
    Patsalos PN; Sander JW
    Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Topiramate: as monotherapy in newly diagnosed epilepsy.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(13):985-92. PubMed ID: 14533950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topiramate--add-on drug for partial seizures.
    Drug Ther Bull; 1996 Aug; 34(8):62-4. PubMed ID: 8810129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital.
    Chappell B; Crawford P
    Seizure; 2005 Sep; 14(6):422-8. PubMed ID: 16087359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical pharmacology of topiramate versus lamotrigine versus phenobarbital: comparison of efficacy and side effects using odds ratios.
    Lathers CM; Schraeder PL; Claycamp HG
    J Clin Pharmacol; 2003 May; 43(5):491-503. PubMed ID: 12751270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.